City
Epaper

After Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

By Lokmat English Desk | Updated: May 16, 2024 13:28 IST

AstraZeneca, which makes Covishield, has admitted that their coronavirus vaccine can cause blood clots in rare cases. The vaccine ...

Open in App

AstraZeneca, which makes Covishield, has admitted that their coronavirus vaccine can cause blood clots in rare cases. The vaccine has also been withdrawn from around the world. In such a situation, Banaras Hindu University has brought to light that there are some other side effects from the coronavirus vaccine which is causing problems for young people and girls. 

Also Read | AstraZeneca Covid vax linked to another rare fatal blood clotting disorder

Research conducted by BHU has shown an increase in the rate of hair loss among the youth. It has also been observed to increase the problem of skin diseases, headaches, and irregular menstrual cycles in young women. The study also found that these problems increased in people who got vaccinated after getting the coronavirus. 

BHU's Institute of Health Sciences conducted a study between January 2022 and August 2023 on 635 young people and 291 above 18 years of age to understand the impact it had on people a year after vaccination. The report was published in the medical journal Springer Link. 

The side effects of the Covaxin vaccine made in India have been studied. Of these, 304 young people and 124 adults reported a viral respiratory tract infection after being vaccinated. The most common adverse outcomes in adolescents were hair loss or skin disorders (10.5%), general disorders (10.2%), and nervous system disorders (4.7%). In adults, general disorders (8.9%), musculoskeletal disorders (5.8%), and nervous system disorders (5.5%) were observed. 

About five percent of women have reported menstrual irregularities since they were vaccinated. 2.7% of women reported experiencing an eye disorder. 

Tags: CovaxinSide EffectsCoronavirusBanaras Hindu UniversityAstrazenecaCovishield
Open in App

Related Stories

TechnologyNew Covid Wave Could Peak by August-End in South Korea; Government Strengthens Response Measures

HealthCOVID-19: Only 2% of Patients Develop Autoantibodies After Recovery, Study Reveals

NationalBHU Study: Black Carbon in Varanasi Sees Steady Decline Since 2012

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

Health Realted Stories

NationalSecurity tightened at Tirumala temple in view of rising India-Pak tensions

NationalDelhi To Conduct Air Raid Siren Test at 3 P.M; Public Advised To Stay Calm

NationalSuspicious Bomb Like Object Found In Jaisalmer After Pakistan Drone, Missile Attack In Rajasthan (Watch Video)

HealthAI-led innovation driving growth in India’s radiology sector: Report

NationalGovt notifies expansion of Credit Guarantee Scheme for Startups